Journey Medical Corporation
DERM
$7.49
$0.040.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.84M | 15.92M | 16.07M | 17.03M | 15.01M |
| Total Other Revenue | 671.00K | 40.00K | 13.00K | 606.00K | -- |
| Total Revenue | 18.51M | 15.96M | 16.08M | 17.63M | 15.01M |
| Cost of Revenue | 6.14M | 6.22M | 5.44M | 5.76M | 4.94M |
| Gross Profit | 12.37M | 9.74M | 10.64M | 11.88M | 10.07M |
| SG&A Expenses | 10.89M | 10.11M | 9.86M | 12.05M | 11.88M |
| Depreciation & Amortization | 969.00K | 1.13M | 1.07M | 1.06M | 1.06M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.05M | 17.45M | 16.52M | 19.16M | 17.89M |
| Operating Income | 456.00K | -1.49M | -443.00K | -1.53M | -2.88M |
| Income Before Tax | -297.00K | -2.23M | -1.25M | -2.32M | -3.74M |
| Income Tax Expenses | 15.00K | -- | 0.00 | -- | 60.00K |
| Earnings from Continuing Operations | -312.00K | -2.23M | -1.25M | -2.32M | -3.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -312.00K | -2.23M | -1.25M | -2.32M | -3.80M |
| EBIT | 456.00K | -1.49M | -443.00K | -1.53M | -2.88M |
| EBITDA | 1.43M | -366.00K | 622.00K | -465.00K | -1.81M |
| EPS Basic | -0.01 | -0.08 | -0.05 | -0.09 | -0.16 |
| Normalized Basic EPS | -0.01 | -0.05 | -0.03 | -0.06 | -0.10 |
| EPS Diluted | -0.01 | -0.08 | -0.05 | -0.09 | -0.16 |
| Normalized Diluted EPS | -0.01 | -0.05 | -0.03 | -0.06 | -0.10 |
| Average Basic Shares Outstanding | 27.49M | 27.31M | 27.11M | 24.96M | 23.29M |
| Average Diluted Shares Outstanding | 27.49M | 27.31M | 27.11M | 24.96M | 23.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |